DUBLIN–(BUSINESS WIRE)–Sep 30, 2020–
The “Global Mice Model Market by Mice Type (Inbred, Knockout), Technology (CRISPR, TALEN, ZFN), Application (Oncology, Diabetes, Immunology), Service (Breeding, Cryopreservation, Genetic Testing), Care Products (Cages, Bedding, Feed), and Region – Forecast to 2025” report has been added to ResearchAndMarkets.com’s offering.
The global mice model market size is projected to reach USD 1.9 billion by 2025 from USD 1.4 billion in 2020, at a CAGR of 6.4% during the forecast period.
The growth of this market is driven mainly by ongoing innovations in mice models, growing demand for personalized medicine, continuous support in the form of grants and investments, growth in the number of pharmaceutical R&D activities, and increasing focus of associations on the development of embryonic stem cells as well as knockout and mutant mice. Moreover, the popularity of humanized mice models and emerging technologies such as Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) will present lucrative opportunities for the market in the coming years.
By mice type, the genetically engineered mice accounted for the fastest-growing segment of the mice model market
Genetically engineered mice segment is anticipated to be the fastest-growing due to the widespread use of these mice in diverse research areas, the emerging CRISPR technology, increasing focus on personalized medicine with the continuous introduction of new models
By service, the breeding segment accounted for the largest share of the mice model market
The breeding segment is expected to account for the largest market share in 2020, with the highest growth rate as well. This can primarily be attributed to the increasing demand for mice models for drug discovery and development and the subsequent increase in the demand for personalized medicines.
Oncology segment expected to grow at the fastest growth rate during the forecast period
Based on application, the mice model market has been segmented into oncology studies, immunology and inflammation studies, endocrine metabolic studies, cardiovascular studies, central nervous system studies (CNS), genetic studies, infectious disease studies, and other disease studies. The endocrine disease studies segment is further segmented into diabetes and other endocrine metabolic disease. The oncology segment is expected to account for the largest market share in 2020, with the highest growth rate as well. This can primarily be attributed to the increasing number of patients who have cancer and the subsequent increase in the demand for cancer therapies.
By technology type, CRISPR/Cas9 accounted for the largest share of the mice model market
CRISPR is the most widely used technology in the mice model market and contributed to the largest share of the mice model market in 2020. Ease of design, high efficiency, and relatively lower cost have increased the demand for CRISPR-customized mice models.
By mice care product, cages segment accounted for the largest share of the mice model market
Based on mice care products, the mice model market has been segmented into cages, feed, bedding, and other products (gnotobiotic equipment, water systems, and accessories). The cages segment accounted for the largest share of the mice model market. This can be attributed to the availability of a wide range of cages designed for specific research needs and the higher cost of cages compared to other care products.
Asia Pacific: The fastest-growing region in the mice model market
The Asia Pacific market is projected to grow at the highest CAGR during the forecast period. Several global pharmaceutical firms have entered the APAC market to tap the significant growth opportunities in emerging Asian countries and lower their production costs by shifting their drug discovery R&D operations and manufacturing to the region. A large number of qualified researchers and low-cost operations in APAC countries, such as India and China, are some of the major factors supporting this trend.
North America: The largest share of the drug discovery services market
North America, which includes the US and Canada, accounted for the largest share of the mice model market. The large share of the North America region can be attributed to the presence of major players operating in the mice model market in the US, growing biomedical research in the US, and rising preclinical activities by CROs and pharmaceutical companies in the region.
- Allentown, LLC
- Charles River Laboratories International
- Crown Bioscience Inc. (Subsidiary of JSR Corporation)
- Cyagen Biosciences
- Fengshi Group
- GVK Bio
- Harbour Biomed
- Ingenious Targeting Laboratory
- Janvier Labs
- Lab Products, Inc.
- Ozgene Pty. Ltd.
- Taconic Biosciences, Inc.
- The Andersons, Inc.
- The Jackson Laboratory
- Trans Genic, Inc.
- Transcure Bioservices
For more information about this report visit https://www.researchandmarkets.com/r/17ab4p
View source version on businesswire.com:https://www.businesswire.com/news/home/20200930005379/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: OTHER SCIENCE SCIENCE
SOURCE: Research and Markets
Copyright Business Wire 2020.
PUB: 09/30/2020 05:43 AM/DISC: 09/30/2020 05:43 AM